Find an Eye MD near you!

The journal Science gained national attention in March 2015 with a news feature on the winner of the National Eye Institute's Audacious Goal Initiative competition. The National Eye Institute's winning choice was “to regenerate neurons and neural connections in the eye and visual system.” The article, entitled “Second Sight: Eye Transplants Are Science Fiction. A Team of Researchers Wants to Change That,” implies this goal is within reach in the foreseeable future.1

Thyroid eye disease (TED) has been found to reduce quality of life for many patients because of changes in their appearance and vision, although some seem to adjust better than others. This study was designed to investigate whether a patient's quality of life changes after having orbital decompression for improvement of appearance, vision, or both, and whether any demographic, clinical, or psychosocial factors can predict which patients might benefit from this surgery.

The field of retina has evolved dramatically over the past decade with the advent of novel pharmacotherapeutics, diagnostic modalities, and surgical techniques. Reflecting this growth in scope and complexity, several subdivisions within retina have been on the increase, particularly dedicated medical retina fellowships.

To assess case-finding performance of the Frequency Doubling Technology Perimeter (FDT) (Carl Zeiss Meditec, Inc., Dublin, CA), Moorfields Motion Displacement Test (MMDT) (Moorfields Eye Hospital, London, UK), iVue optical coherence tomography (OCT) (Optovue Inc., Fremont, CA), and ocular response analyzer (ORA) (Reichert Ophthalmic Instruments, Depew, NY), alone or combined, for primary open-angle glaucoma (POAG).